| | | | | | | |
 | GILEAD SCIENCES, INC. | -0.24% | 1.40% | -13.25% | -9.81% | -1.55% | 79 138 |
| VERTEX PHARMACEUTICALS | 0.08% | 7.54% | 34.80% | 51.61% | 64.60% | 75 853 |
| REGENERON PHARMACEUTICALS, INC. | -0.42% | 5.37% | 1.15% | 4.98% | 115.90% | 68 581 |
 | WUXI APPTEC CO., LTD. | -2.77% | -4.41% | -23.13% | -37.42% | 134.94% | 39 243 |
| BIONTECH SE | 2.00% | -9.71% | -36.33% | -54.30% | --.--% | 39 107 |
 | GENMAB A/S | 4.57% | 0.23% | 2.70% | -4.93% | 111.76% | 23 466 |
 | ARGENX SE | 1.92% | -1.35% | 15.89% | 37.68% | 189.77% | 20 432 |
| BEIGENE, LTD. | 3.60% | 12.76% | -26.82% | -29.12% | 46.49% | 19 802 |
| NEUROCRINE BIOSCIENCES, INC. | 0.03% | 13.53% | 25.42% | 23.95% | 12.69% | 10 207 |
| SAREPTA THERAPEUTICS, INC. | -0.84% | 17.65% | 24.51% | 38.61% | -9.68% | 9 901 |
| LEGEND BIOTECH CORPORATION | -0.41% | 1.58% | 4.44% | 21.67% | --.--% | 7 961 |
| KARUNA THERAPEUTICS, INC. | -0.89% | 101.52% | 95.87% | 131.64% | 1,045.50% | 7 755 |
| EXELIXIS, INC. | -0.72% | -8.88% | 5.91% | 10.95% | -2.07% | 6 254 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | -14.68% | 47.14% | 9.01% | 41.36% | --.--% | 6 151 |
| HALOZYME THERAPEUTICS, INC. | -1.92% | -7.12% | 7.57% | 6.15% | 173.25% | 6 076 |
| | | | | | | |
| | Promedio | -0.71% | 11.82% | 8.52% | 15.53% | 156.80% | |
| | Media ponderada por Capi. | 0.05% | 4.84% | 1.47% | 5.11% | 94.41% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
